Ranibizumab Intraocular and Triprolidine, pseudoephedrine, and codeine
Determining the interaction of Ranibizumab Intraocular and Triprolidine, pseudoephedrine, and codeine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: codeine / pseudoephedrine / triprolidine
Brand name:
Synonyms: Triprolidine, pseudoephedrine, and codeine (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Triptodur
- Ranibizumab Intraocular-Triptodur (Triptorelin (CPP))
- Ranibizumab Intraocular-Triptodur (Triptorelin)
- Ranibizumab Intraocular-Triptone
- Ranibizumab Intraocular-Triptorelin
- Ranibizumab Intraocular-Triptorelin (CPP)
- Triprolidine, pseudoephedrine, and codeine-Ranibizumab ophthalmic
- Triprolidine, pseudoephedrine, and codeine-Ranitidine
- Triprolidine, pseudoephedrine, and codeine-Ranitidine Capsule
- Triprolidine, pseudoephedrine, and codeine-Ranitidine Hydrochloride
- Triprolidine, pseudoephedrine, and codeine-Ranitidine Injection
- Triprolidine, pseudoephedrine, and codeine-Ranitidine Suspension